Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-09-19 12:23 pm Purchase | 2025-09-12 | 13G | BioCryst Pharmaceuticals, Inc. BCRX | Deerfield Mgmt, L.P. | 12,169,000 5.800% | 5,793,857![]() (+90.88%) | Filing History |
2025-08-22 4:07 pm Sale | 2025-08-22 | 13G | Brookdale Senior Living Inc. BKD | Deerfield Mgmt, L.P. | 11,637,032 4.900% | -3,725,232![]() (-24.25%) | Filing History |
2025-08-18 5:59 pm Purchase | 2025-08-11 | 13G | BridgeBio Oncology Therapeutics Inc. BBOT | Deerfield Mgmt, L.P. | 4,885,446 6.170% | 4,885,446![]() (New Position) | Filing History |
2025-08-14 08:19 am Purchase | 2025-06-30 | 13G | Brookdale Senior Living Inc. BKD | Deerfield Mgmt, L.P. | 15,362,264 6.470% | 569,000![]() (+3.85%) | Filing History |
2025-08-01 6:06 pm Sale | 2025-07-30 | 13D | ARS Pharmaceuticals, Inc. SPRY | Deerfield Mgmt, L.P. | 7,610,217 7.750% | -1,023,320![]() (-11.85%) | Filing History |
2025-07-31 6:26 pm Purchase | 2025-07-31 | 13D | Larimar Therapeutics, Inc. LRMR | Deerfield Mgmt, L.P. | 30,667,474 35.810% | 9,394,000![]() (+44.16%) | Filing History |
2025-07-22 7:38 pm Sale | 2025-07-18 | 13D | ARS Pharmaceuticals, Inc. SPRY | Deerfield Mgmt, L.P. | 8,633,537 8.790% | -1,090,971![]() (-11.22%) | Filing History |
2025-07-11 08:19 am Purchase | 2025-07-07 | 13G | Cogent Biosciences, Inc. COGT | Deerfield Mgmt, L.P. | 9,053,118 6.490% | 6,086,773![]() (+205.19%) | Filing History |
2025-07-02 08:24 am Sale | 2025-07-02 | 13D | ARS Pharmaceuticals, Inc. SPRY | Deerfield Mgmt, L.P. | 9,724,508 9.900% | -790,149![]() (-7.51%) | Filing History |
2025-06-11 5:38 pm Purchase | 2025-06-06 | 13G | Vera Therapeutics, Inc. VERA | Deerfield Mgmt, L.P. | 3,348,117 5.250% | 3,348,117![]() (New Position) | Filing History |
2025-05-13 8:50 pm Sale | 2025-03-31 | 13G | Owens & Minor, Inc. OMI | Deerfield Mgmt, L.P. | 0 0.000% | -5,229,779![]() (Position Closed) | Filing History |
2025-05-13 8:50 pm Purchase | 2025-03-31 | 13G | Indivior PLC INDV | Deerfield Mgmt, L.P. | 10,567,160 8.470% | 1,684,000![]() (+18.96%) | Filing History |
2025-05-13 8:50 pm Sale | 2025-03-31 | 13G | Embecta Corp. EMBC | Deerfield Mgmt, L.P. | 2,720,535 4.660% | -354,800![]() (-11.54%) | Filing History |
2025-05-13 8:49 pm Sale | 2025-03-31 | 13G | MALLINCKRODT PLC SHS MNKTQ | Deerfield Mgmt, L.P. | 804,259 4.070% | -655,974![]() (-44.92%) | Filing History |
2025-03-24 7:57 pm Sale | 2025-03-20 | 13D | ARS Pharmaceuticals, Inc. SPRY | Deerfield Mgmt, L.P. | 10,514,657 10.720% | -563,270![]() (-5.08%) | Filing History |
2025-03-03 7:04 pm Purchase | 2025-02-27 | 13D | BiomX Inc. PHGE | Deerfield Mgmt, L.P. | 15,558,445 9.990% | 0![]() (+0.00%) | Filing History |
2025-02-25 9:18 pm Sale | 2025-02-21 | 13D | Singular Genomics Systems, Inc. OMIC | Deerfield Mgmt, L.P. | 1,000 100.000% | -248,495![]() (-99.60%) | Filing History |
2025-02-13 09:40 am Sale | 2025-02-13 | 13G | DocGo Inc. DCGO | Deerfield Mgmt, L.P. | 5,051,500 4.950% | -4,014,638![]() (-44.28%) | Filing History |
2025-02-13 09:39 am Purchase | 2024-12-31 | 13G | Indivior PLC INDV | Deerfield Mgmt, L.P. | 8,883,160 7.160% | 1,519,950![]() (+20.64%) | Filing History |
2025-02-13 08:59 am Sale | 2024-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | Deerfield Mgmt, L.P. | 534,737 0.760% | -6,180,764![]() (-92.04%) | Filing History |